// App-Quantinova.ai

PB0999 : Long-Term Immunogenicity, Efficacy and Safety of Simoctocog Alfa in Patients with Severe Haemophilia A who Had Completed the NuProtect PUP Study

Researchers

Presenter

  • R.J. Liesner

Principal Investigators

  • N/A

Medical Centers

  • Haemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • simoctocog alfa

Outcome

  • N/A

Study Design

  • Open Label

  • Multinational

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved